TR201722039A2 - SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE - Google Patents

SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE Download PDF

Info

Publication number
TR201722039A2
TR201722039A2 TR2017/22039A TR201722039A TR201722039A2 TR 201722039 A2 TR201722039 A2 TR 201722039A2 TR 2017/22039 A TR2017/22039 A TR 2017/22039A TR 201722039 A TR201722039 A TR 201722039A TR 201722039 A2 TR201722039 A2 TR 201722039A2
Authority
TR
Turkey
Prior art keywords
mesalazine
pharmaceutical compositions
solid oral
oral pharmaceutical
derivatives
Prior art date
Application number
TR2017/22039A
Other languages
Turkish (tr)
Inventor
Zengi̇ner Si̇bel
Türkyilmaz Ali̇
Taşkin Abdullah
Yanç Burçi̇n
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/22039A priority Critical patent/TR201722039A2/en
Priority to PCT/TR2018/050894 priority patent/WO2019132837A1/en
Publication of TR201722039A2 publication Critical patent/TR201722039A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, mesalazin veya mesalazinin farmasötik olarak kabul edilebilir bir tuzunu içeren farmasötik kompozisyonlarla ilgili olup; burada söz konusu kompozisyon, akrilik asit ve metakrilik asit ve bunların türevlerini içermemektedir.The present invention relates to pharmaceutical compositions containing mesalazine or a pharmaceutically acceptable salt of mesalazine; wherein the composition does not contain acrylic acid and methacrylic acid and their derivatives.

TR2017/22039A 2017-12-27 2017-12-27 SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE TR201722039A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2017/22039A TR201722039A2 (en) 2017-12-27 2017-12-27 SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE
PCT/TR2018/050894 WO2019132837A1 (en) 2017-12-27 2018-12-25 Solid oral pharmaceutical compositions of mesalazine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/22039A TR201722039A2 (en) 2017-12-27 2017-12-27 SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE

Publications (1)

Publication Number Publication Date
TR201722039A2 true TR201722039A2 (en) 2019-07-22

Family

ID=65494484

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/22039A TR201722039A2 (en) 2017-12-27 2017-12-27 SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE

Country Status (2)

Country Link
TR (1) TR201722039A2 (en)
WO (1) WO2019132837A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112315929B (en) * 2019-07-20 2022-10-28 辽宁华瑞联合制药有限公司 Composition of four-layer coating system mesalazine enteric-coated tablet and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690824A (en) * 1983-07-07 1987-09-01 Redi-Rowell, Inc. Solid pharmaceutical formulations for slow, zero order release via controlled surface erosion: expanded range
JPH07223970A (en) * 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd Releasing formulation at niche in digestive tract
WO1998026767A2 (en) * 1996-12-17 1998-06-25 Poli Industria Chimica S.P.A. Site-specific controlled release dosage formulation for mesalamine
US20090169622A1 (en) * 2007-12-27 2009-07-02 Roxane Laboratories, Inc. Delayed-release oral pharmaceutical composition for treatment of colonic disorders
EP3162362A1 (en) * 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Optimized high-dose tablet of mesalazine
JP2019513800A (en) * 2016-04-19 2019-05-30 フェリング ベスローテン フェンノートシャップ Oral pharmaceutical composition of mesalazine

Also Published As

Publication number Publication date
WO2019132837A1 (en) 2019-07-04

Similar Documents

Publication Publication Date Title
CY1124726T1 (en) QUINAZOLINE DERIVATIVES USED TO TREAT HIV
DOP2020000102A (en) HELPFUL COMPOUNDS TO INHIBIT CDK7
BR112018003026A2 (en) compositions comprising a pi3k inhibitor and an hdac inhibitor
AR107864A1 (en) ACID 7a, 11b-DIHIDROXI-6a-ETIL-5b-COLAN-24-OICO AND PHARMACEUTICAL COMPOSITIONS
CL2018001199A1 (en) Comprimido de tres capas que comprende un compuesto de formula i, tenofovir alafenamida y emtricitabina; su uso en el tratamiento de una infeccion por vih.
UY35933A (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE AZD9291
CY1123372T1 (en) ORAL PHARMACEUTICAL COMPOSITION
CL2017003320A1 (en) Pharmaceutical formulations containing tenofovir and emtricitabine
AR122580A2 (en) DOSAGE FORM OF DOXYLAMINE AND PYRIDOXINE AND/OR THEIR METABOLITES OR SALTS
EA201891267A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING EFFECTIVE URAT1 INHIBITOR
EA201990388A1 (en) CXCR7 PIPERIDINE MODULATORS
BR112018074985A2 (en) antibacterial compositions
SA518390920B1 (en) Novel annelated phenoxyacetamides
EA201890532A1 (en) NEW ANNELED BENZAMIDES
EA202092829A1 (en) CONTROLLED RELEASE TOPACITINIB COMPOSITIONS
MA40366A (en) TETRAHYDROQUINOLINE DERIVATIVES AS BROMODOMA INHIBITORS
AR090975A1 (en) N-ETIL-4-HYDROXYL-1-METHYL-5- (METHYL (2,3,4,5,6-PENTAHYDROXIHEXIL) AMINO) -2-OXO-N-PHENYL-1,2-DIHYDROCHINOLINE-3-CARBOXAMIDE
MA40781A (en) PHARMACEUTICAL COMPOSITION OF LOW DOSAGE ISOTRETINOIN FOR ORAL USE
AR090073A1 (en) N-ETIL-N-PHENYL-1,2-DIHIDRO-4,5-DI-HYDROXI-1-METHYL-2-OXO-3-CHINOLINACARBOXAMIDE, ITS PREPARATION AND USES
WO2016142821A3 (en) Compositions containing a thrombin inhibitor
TR201819805T4 (en) FLAVAGLIN DERIVATIVES.
EA201892539A1 (en) PYRIDINYL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION AS AOS3 Inhibitors
TR201009394A2 (en) Improved montelukast formulations.
MA49947A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA-AMYLOID ANTIBODIES
TR201722039A2 (en) SOLID ORAL PHARMACEUTICAL COMPOSITIONS OF MESALAZINE